Icahn School of Medicine at Mount Sinai
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Douglas Tremblay
By
Insights from 2023 ASH Annual Meeting
FEATURING
Douglas Tremblay
Login to view comments.
Click here to Login